Detalhe da pesquisa
1.
Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration.
Qual Life Res
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630166
2.
Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019-2022.
BMC Public Health
; 24(1): 380, 2024 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317148
3.
Direct and indirect medical costs of bladder cancer in Iran.
Cost Eff Resour Alloc
; 21(1): 5, 2023 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647054
4.
A national survey of Iranian general population to estimate a value set for the EQ-5D-5L.
Qual Life Res
; 32(7): 2079-2087, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897530
5.
Payment systems for dialysis and their effects: a scoping review.
BMC Health Serv Res
; 23(1): 45, 2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650516
6.
The economic burden of osteoporosis in Iran in 2020.
Osteoporos Int
; 33(11): 2337-2346, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821307
7.
A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma.
Cost Eff Resour Alloc
; 20(1): 16, 2022 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35366919
8.
National geographical pattern of COVID-19 hospitalization, case fatalities, and associated factors in patients covered by Iran Health Insurance Organization.
BMC Public Health
; 22(1): 1274, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35773657
9.
Public preferences regarding the priority setting criteria of health interventions for budget allocation: results of a survey of Iranian adults.
BMC Public Health
; 22(1): 2038, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344950
10.
The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran.
Med J Islam Repub Iran
; 36: 73, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128278
11.
Estimating the Prevalence of Bladder Cancer by Stage in Iran as a Developing Country.
Med J Islam Repub Iran
; 36: 37, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128281
12.
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds.
Cost Eff Resour Alloc
; 19(1): 7, 2021 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33541364
13.
The impact of common chronic conditions on health-related quality of life: a general population survey in Iran using EQ-5D-5L.
Cost Eff Resour Alloc
; 19(1): 28, 2021 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985522
14.
Application of discrete choice experiments to estimate value of life: a national study protocol in Iran.
Cost Eff Resour Alloc
; 19(1): 6, 2021 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516226
15.
Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran.
Cost Eff Resour Alloc
; 19(1): 29, 2021 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985531
16.
Economic burden of medication-overuse headache in Iran: direct and indirect costs.
Neurol Sci
; 42(5): 1869-1877, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32948933
17.
Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran.
BMC Public Health
; 21(1): 926, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001057
18.
Direct costs of common osteoporotic fractures (Hip, Vertebral and Forearm) in Iran.
BMC Musculoskelet Disord
; 22(1): 651, 2021 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34332559
19.
Correction to: Health-related quality of life measured using the EQ-5D-5 L: population norms for the capital of Iran.
Health Qual Life Outcomes
; 18(1): 147, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438918
20.
Health-related quality of life measured using the EQ-5D-5 L: population norms for the capital of Iran.
Health Qual Life Outcomes
; 18(1): 108, 2020 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334604